GALD EBS Week ended 31 Jul 2026

Weekly Investor Report

Name: GALD weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

GALDERMA GROUP N · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data

Latest close 175.8 CHF

1.2% latest week

Weekly setup

Mixed setup

The weekly trend is active. Price is 9.7% above the Trend Line and sits at 80.4% of its 52-week range. The latest completed week returned 1.2%, after a -2.1% four-week move. The latest news-sentiment score is 54/100.

Setup score 65 out of 100

Latest Close 175.8 CHF 31 Jul 2026

1W Return 1.2% latest completed week

4W Return -2.1% short-term follow-through

12W Return 7.2% quarterly tape

Trend Breadth 92.3% 48 of 52 weeks active

Volume Ratio 1.1x vs 13-week average

What is working

The trend backdrop is active with a 17-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.

What could go wrong

13 reversal markers appear in the recent smart-money tape.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 1.2% Latest completed week; four-week move -2.1%. Indicator stack 96/60 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 66.64% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 9 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 9.7% above the Trend Line and sits at 80.4% of its 52-week range. The latest completed week returned 1.2%, after a -2.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

124.5 CHF 80.4% 188.2 CHF

Range location80.4%Shows where the latest close sits between the 52-week low and high.

Trend distance9.7%Price premium or discount versus the weekly Trend Line.

Fair-value gap50.6%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-6.6%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9012-week average 0.72

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.90Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers1313 reversal markers

No recent accumulation markers. 13 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.1% over four weeks, 7.2% over 12 weeks, and 38.1% over one year. The current trend has remained active for 17 consecutive weeks.

Performance by holding period

1W1.2%

4W-2.1%

12W7.2%

26W22.4%

52W38.1%

Active trend streak17 weeks

Active weeks in one year48

Trend breadth92.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.75Latest activity-pressure read.

Pressure change-38.5%Four-week change in activity pressure.

Leadership3.82Latest relative-leadership reading.

RS change-40.7%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 9 relevant articles.

3 positive · 5 neutral · 1 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-6.6%Distance below the 52-week high.

13-week volatility3.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher18 of 268 weeks finished lower.

Best week+6.9%Week of 6 Mar.

Worst week-7.8%Week of 13 Mar.

Latest week+1.2%Week of 31 Jul.

Shape of recent returns

Strong gains5

Modest gains13

Flat weeks0

Modest losses5

Sharp losses3

Recent vol3.1%13-week weekly-return volatility.

Base vol3.5%52-week weekly-return volatility.

Up/down split34/18Count of positive and negative weeks in the 52-week window.

Average skew2.8% / -3.3%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorCH Healthcare

4-week rank23 / 40

Group average-1.1%

Trend breadth47.5%

Trend47.5%active weekly trend signals

MD62.5%positive activity pressure

RS42.5%positive relative leadership

Four-week leaders

KURN · EBS19.6%SOON · EBS8.1%YPSN · EBS7.8%METN · EBS7.4%SFZN · EBS6.6%

IndustryCH Drug Manufacturers - Specialty & Generic

4-week rank2 / 5

Group average-5.2%

Trend breadth80.0%

Trend80.0%active weekly trend signals

MD40.0%positive activity pressure

RS80.0%positive relative leadership

Four-week leaders

SFZN · EBS6.6%GALD · EBS-2.1%SDZ · EBS-8.7%CURN · EBS-10.6%PPGN · EBS-11.3%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape68/100

Trend, activity pressure, participation, and risk combine to a 68/100 tape read.

Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.90; 13 reversal markers Next-Week ExpectancyPositive 66.64%

Next-week expectancy is positive with a 66.64% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 9 relevant articles.

Galderma falls after FDA issues second setback for Botox rival By Investing.com Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	175.8 CHF	1.2%	160.2 CHF	116.7 CHF	0.75	3.82	2.0M	On
24 Jul 2026	173.6 CHF	0.7%	159.8 CHF	116.2 CHF	0.99	2.96	1.9M	On
17 Jul 2026	172.5 CHF	-0.2%	159.4 CHF	115.7 CHF	1.13	2.31	1.7M	On
10 Jul 2026	172.9 CHF	-3.7%	159.1 CHF	115.3 CHF	1.26	3.55	1.8M	On
3 Jul 2026	179.6 CHF	0.7%	158.8 CHF	114.8 CHF	1.22	6.44	2.8M	On
26 Jun 2026	178.2 CHF	3.4%	158.2 CHF	114.3 CHF	0.88	8.02	323.0K	On
19 Jun 2026	172.4 CHF	0.1%	157.6 CHF	113.7 CHF	0.68	7.98	3.1M	On
12 Jun 2026	172.1 CHF	6.6%	156.8 CHF	113.2 CHF	0.44	8.90	418.8K	On
5 Jun 2026	161.5 CHF	-3.0%	156.0 CHF	112.7 CHF	0.32	5.21	236.4K	On
29 May 2026	166.6 CHF	5.0%	155.4 CHF	112.3 CHF	0.40	7.75	2.6M	On
22 May 2026	158.6 CHF	1.3%	154.8 CHF	111.8 CHF	0.41	3.55	2.0M	On
15 May 2026	156.6 CHF	-4.4%	154.2 CHF	111.4 CHF	0.44	5.04	1.6M	On
8 May 2026	163.9 CHF	0.1%	153.6 CHF	111.0 CHF	0.31	11.60	2.2M	On
1 May 2026	163.8 CHF	0.9%	152.8 CHF	110.5 CHF	0.09	12.05	1.8M	On

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.